Infusion pump comparison for healthcare procurement is a structured evaluation of the complete pump-and-consumable program, not a feature check against a single specification sheet. The most frequently reported device problems span software error messages, human factors, broken components, battery failure, alarm failure, and over or under infusion [1]. A useful comparison therefore begins with clinical use segmentation, moves through mandatory versus preferred specifications, examines regulatory documentation, and closes with acceptance conditions and a concrete evaluation example. The goal is to link the original clinical need to testable requirements, comparable evidence, documented acceptance, and post-award performance review [2]. This article describes that named workflow, the technical decision points, the evidence limits, and a hypothetical comparison of two large-volume pumps to illustrate how the process works without inventing a winner.
Separate Clinical Use Before Comparing Devices
Clinical use should separate ICU, anesthesia, neonatal, emergency, chemotherapy, and ward infusion needs because accuracy, drug library, disposable sets, and alarm tolerance differ [2]. A pump appropriate for adult ward hydration may fail a neonatal unit's low-flow accuracy requirement or an anesthesia team's syringe-loading workflow. Procurement teams that skip this segmentation risk comparing devices against a single blended requirement that no pump can satisfy well.
The intended use environment and treatment population also shape the comparison. FDA recommends that indications for use address the intended use environment, the intended routes of administration, any specific uses such as patient-controlled analgesia, and the indicated treatment population [1]. A device labeled for adult, pediatric, and neonatal populations, for example, must be assessed differently from one restricted to adult use. The comparison matrix should therefore record which clinical areas each candidate can lawfully serve [2].
Compare the Pump-and-Consumable Ecosystem Over Five Years
A common buying mistake is accepting a low pump price tied to expensive proprietary sets, unclear library licensing, inadequate spare pool, weak air or occlusion testing, or unsupported network and security infrastructure [2]. Comparison should therefore extend to dedicated IV sets or cassettes, administration-set variants, air-elimination accessories, pole clamps, racks, batteries or chargers, drug-library or server licenses, barcode accessories if used, and fleet spare units [2].
The five-year ecosystem view also includes library management, fleet maintenance, spares, training, and pump replacement pool [2]. A pump whose drug-library governance requires recurring server licenses may carry materially different total cost than one whose library updates run through existing biomedical infrastructure. Vendors should be asked to validate actual sets, air and occlusion alarms, anti-free-flow protection, drug-library governance, battery, cleaning, and fleet support during demonstration, not merely in written specifications [2].
Acceptance Conditions Before Award and Release
Acceptance should verify flow accuracy at low and routine rates, alarm operation, battery runtime, consumable compatibility, supplied clamps or racks, user training, and biomedical baseline results [2]. Acceptance records should capture all accessories by quantity, serial numbers where applicable, battery test, alarm checks, safety and performance verification, user training, biomedical preventive maintenance requirements, and warranty start date [2].
Do not release to clinical use until user checklists and cleaning instructions are available at the point of use [2]. A suggested demonstration workflow is to have biomedical staff run occlusion and air-in-line alarm checks at minimum, intermediate, and maximum delivery rates, while a clinical user completes a standard programming sequence and a cleaning cycle. This workflow is proposed here as an editorial suggestion only; no testing has been conducted for this article [6].
Define Mandatory and Preferred Specifications
Mandatory requirements should specify approved IV sets, flow range and accuracy, air-in-line detection, upstream and downstream occlusion behavior, anti-free-flow protection, bolus limits, drug library, battery runtime, event log, and network update process [2]. These become pass-fail criteria. Preferred specifications can then rank candidates on screen quality, interoperability, fleet analytics, and battery management without letting those preferences override safety-critical requirements [2].
Regulatory documentation provides a parallel specification source. For a 510(k) submission, FDA recommends a table comparing the device to a legally marketed predicate, including indications for use, patient population, intended use environment, flow accuracy specifications, time to occlusion alarm, dimensions, weight, ingress protection, power, and units of delivery [1]. Procurement can request this comparison table and use the listed specifications as objective inputs, while recognizing that predicate comparison is not a performance guarantee for the purchasing hospital's specific use conditions.
Use Human Factors and Regulatory Evidence as Decision Inputs
Published studies using human factors and ergonomics evaluations exist to support purchasing decisions within infusion pump bidding processes [7]. Heuristic evaluation and simulated use testing of infusion pumps have been used to inform pump selection, suggesting that usability tasks applied during procurement can reveal programming or alarm-response problems that specification sheets conceal [7]. Procurement teams should consider structured usability testing with representative clinical users as part of the comparison.
For ACE pumps, regulation requires design verification and validation to include a human factors study demonstrating that an intended user can safely use the device for its intended use [8]. The device must also store critical events including drug delivery records, pump commands and confirmations, malfunctions, alarms and acknowledgements, and connectivity events [8]. When comparing interoperable pumps, procurement should ask for validated interface specifications and the wireless quality of service required for proper operation [8].
A Concrete Evaluation Example: Plum 360, Plum Solo, and Plum Duo
A hypothetical comparison of three large-volume pumps from ICU Medical illustrates how a procurement team might structure the decision without declaring a winner. The vendor's comparison guide lists flow rate accuracy of plus or minus 10 percent for the Plum 360 at 0.1 to 0.9 mL/hr and plus or minus 5 percent at 1 to 999 mL/hr, while the Plum Solo and Plum Duo list plus or minus 3 percent across 0.1 to 999 mL/hr [6]. This is a vendor-provided document and should be verified through independent acceptance testing.
The same guide shows the Plum Solo and Plum Duo with touch screens and color displays, while certain features such as auto-flush with piggyback are marked differently across the three devices [6]. Procurement would map these attributes to the clinical use segmentation: a unit requiring low-flow neonatal accuracy might weigh the documented accuracy specification, while a unit needing dual-channel independent delivery might compare the Plum Duo's two channels against single-channel alternatives. None of these vendor claims establishes clinical superiority, and no independent head-to-head performance data is supplied in the source.
Sources & references
- Infusion Pumps Total Product Life Cycle — Guidance for Industry and FDA Staff (December 2, 2014) · www.fda.gov
- Infusion Pump Buying Guide, RFQ and Vendor Evaluation | Biomedical Equipment Guide · www.medequipguide.org
- Pump Selection Practice Standard | NHIA · nhia.org
- [PDF] Infusion Pumps Total Product Life Cycle - FDA · www.fda.gov
- Article - External Infusion Pumps - Policy Article (A52507) · www.cms.gov
- Comparison Guide—Large Volume Pumps · www.icumed.com
- Frontiers | A review of human factors and infusion pumps: lessons for procurement · www.frontiersin.org
- 21 CFR § 880.5730 Alternate controller enabled infusion pump. · www.ecfr.gov